These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11903686)

  • 1. Changes in cellular immunity during chemotherapy for testicular cancer.
    Kubota Y; Ohji H; Itoh K; Sasagawa I; Nakada T
    Int J Urol; 2001 Nov; 8(11):604-8. PubMed ID: 11903686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Difficulty in evaluation of the effectiveness of BEP chemotherapy in a patient with testicular seminoma].
    Ohsugi H; Kinoshita H; Kawa G; Matsuda T
    Hinyokika Kiyo; 2013 Jun; 59(6):389-93. PubMed ID: 23827875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kinetics of peripheral blood CD34-positive cells and the optimum timing for harvesting peripheral blood stem cells during BEP chemotherapy in patients with testicular germ cell tumor].
    Hioki T; Ogawa K; Yamada Y; Fumino M; Sugimura Y
    Nihon Hinyokika Gakkai Zasshi; 2000 Jan; 91(1):14-20. PubMed ID: 10689878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983.
    de Wit R; Skoneczna I; Daugaard G; De Santis M; Garin A; Aass N; Witjes AJ; Albers P; White JD; Germa-Lluch JR; Marreaud S; Collette L
    J Clin Oncol; 2012 Mar; 30(8):792-9. PubMed ID: 22271474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor.
    Saxman SB; Nichols CR; Einhorn LH
    Chest; 1997 Mar; 111(3):657-60. PubMed ID: 9118704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease.
    Krainer M; Wolf H; Michl I; Wiltschke C; Budinsky A; Kaider A; Kratzik C; Eibl MM; Zielinski CC
    Cancer; 1995 Jan; 75(2):539-44. PubMed ID: 7529130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful collection of peripheral blood stem cells mobilized by high-dose etoposide for patients with chemotherapy-resistant and/or poor prognostic testicular cancer].
    Nakagawa S; Sugimoto K; Mikami K; Watanabe H; Sonoda Y; Kuzuyama Y; Abe T; Fujii H
    Nihon Hinyokika Gakkai Zasshi; 1994 Apr; 85(4):571-8. PubMed ID: 7514697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BEP (bleomycin, etoposide, cisplatinum) chemotherapy as an induction therapy of advanced extragonadal germ cell tumor].
    Goto S; Fukui I; Ando M; Kihara K; Kitahara S; Tsujii T; Noro A; Hagiwara T; Toyoshima T; Tsukamoto T
    Hinyokika Kiyo; 1991 Dec; 37(12):1689-93. PubMed ID: 1723842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
    Mardiak J; Sálek T; Sycová-Milá Z; Obertová J; Recková M; Mego M; Hlavatá Z; Brozmanová K; Risnyovzská Z; Svetlovská D; Koza I
    Neoplasma; 2007; 54(3):240-5. PubMed ID: 17447857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effective administration of recombinant granulocyte colony-stimulating factor to prevent granulocytopenia due to combination chemotherapy for testicular germ cell tumors].
    Nonomura K; Shinohara N; Shinno Y; Seki T; Koyanagi T; Nagamori S; Fujieda J; Togashi M; Ohashi N; Abe N; Toyota K; Maru A; Gotoh T; Sakakibara N; Sakashita S; Kosugi M; Adachi Y
    Hinyokika Kiyo; 1996 Sep; 42(9):699-704. PubMed ID: 8918674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary leukemia following ultra high-dose chemotherapy with peripheral blood stem cell autotransplantation for refractory testicular cancer].
    Matsumoto S; Matsuda H; Uejima S; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):687-91. PubMed ID: 11109821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient increase in mitogen-induced lymphoproliferative responses in patients with testicular cancer after BEP chemotherapy.
    Krainer M; Wolf HM; Wiltschke C; Wilfing A; Kaider A; Kratzik C; Eibl MM; Zielinski CC
    Urology; 2000 Jun; 55(6):934-8. PubMed ID: 10840113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin.
    Brugger W; Birken R; Bertz H; Hecht T; Pressler K; Frisch J; Schulz G; Mertelsmann R; Kanz L
    Br J Haematol; 1993 Jul; 84(3):402-7. PubMed ID: 7692928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial thrombosis after cisplatin-based chemotherapy for metastatic germ cell tumors.
    Cheng E; Berthold DR; Moore MJ; Duran I
    Acta Oncol; 2009; 48(3):475-7. PubMed ID: 18932096
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of metastatic seminoma by chemotherapy.: an experience].
    Komatsubara S; Itoi T; Watanabe M; Kitamura Y; Koike T
    Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):666-72. PubMed ID: 11109817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.
    de Wit R; Roberts JT; Wilkinson PM; de Mulder PH; Mead GM; Fosså SD; Cook P; de Prijck L; Stenning S; Collette L
    J Clin Oncol; 2001 Mar; 19(6):1629-40. PubMed ID: 11250991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
    Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
    Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.